S&P 500   3,815.96 (+1.74%)
DOW   30,868.78 (+1.87%)
QQQ   323.95 (+1.42%)
AAPL   139.03 (-2.13%)
MSFT   239.44 (+2.81%)
FB   273.59 (+0.53%)
GOOGL   1,858.57 (+2.18%)
AMZN   3,276.20 (+1.35%)
TSLA   843.92 (-2.34%)
NVDA   524.93 (+1.59%)
BABA   260.07 (-0.07%)
CGC   38.99 (+3.07%)
GE   11.20 (-1.58%)
MU   78.69 (+4.79%)
AMD   88.45 (-0.44%)
NIO   58.04 (+1.56%)
T   29.37 (+0.79%)
F   10.89 (+0.93%)
ACB   11.65 (+4.02%)
BA   197.02 (+1.54%)
DIS   169.90 (+4.21%)
NFLX   543.03 (+3.77%)
GILD   65.65 (+0.26%)
S&P 500   3,815.96 (+1.74%)
DOW   30,868.78 (+1.87%)
QQQ   323.95 (+1.42%)
AAPL   139.03 (-2.13%)
MSFT   239.44 (+2.81%)
FB   273.59 (+0.53%)
GOOGL   1,858.57 (+2.18%)
AMZN   3,276.20 (+1.35%)
TSLA   843.92 (-2.34%)
NVDA   524.93 (+1.59%)
BABA   260.07 (-0.07%)
CGC   38.99 (+3.07%)
GE   11.20 (-1.58%)
MU   78.69 (+4.79%)
AMD   88.45 (-0.44%)
NIO   58.04 (+1.56%)
T   29.37 (+0.79%)
F   10.89 (+0.93%)
ACB   11.65 (+4.02%)
BA   197.02 (+1.54%)
DIS   169.90 (+4.21%)
NFLX   543.03 (+3.77%)
GILD   65.65 (+0.26%)
S&P 500   3,815.96 (+1.74%)
DOW   30,868.78 (+1.87%)
QQQ   323.95 (+1.42%)
AAPL   139.03 (-2.13%)
MSFT   239.44 (+2.81%)
FB   273.59 (+0.53%)
GOOGL   1,858.57 (+2.18%)
AMZN   3,276.20 (+1.35%)
TSLA   843.92 (-2.34%)
NVDA   524.93 (+1.59%)
BABA   260.07 (-0.07%)
CGC   38.99 (+3.07%)
GE   11.20 (-1.58%)
MU   78.69 (+4.79%)
AMD   88.45 (-0.44%)
NIO   58.04 (+1.56%)
T   29.37 (+0.79%)
F   10.89 (+0.93%)
ACB   11.65 (+4.02%)
BA   197.02 (+1.54%)
DIS   169.90 (+4.21%)
NFLX   543.03 (+3.77%)
GILD   65.65 (+0.26%)
S&P 500   3,815.96 (+1.74%)
DOW   30,868.78 (+1.87%)
QQQ   323.95 (+1.42%)
AAPL   139.03 (-2.13%)
MSFT   239.44 (+2.81%)
FB   273.59 (+0.53%)
GOOGL   1,858.57 (+2.18%)
AMZN   3,276.20 (+1.35%)
TSLA   843.92 (-2.34%)
NVDA   524.93 (+1.59%)
BABA   260.07 (-0.07%)
CGC   38.99 (+3.07%)
GE   11.20 (-1.58%)
MU   78.69 (+4.79%)
AMD   88.45 (-0.44%)
NIO   58.04 (+1.56%)
T   29.37 (+0.79%)
F   10.89 (+0.93%)
ACB   11.65 (+4.02%)
BA   197.02 (+1.54%)
DIS   169.90 (+4.21%)
NFLX   543.03 (+3.77%)
GILD   65.65 (+0.26%)
Log in
CVE:KLH

(KLH.V) Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume5,576 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Stellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a range of diseases. The Company's core business is developing and commercializing Keyhole Limpet Hemocyanin for use in immunotherapy and immunodiagnostic applications. The Company's Stellar KLH product offerings include Stellar KLH protein for conjugation and as carrier molecule in immunotherapy development; Stellar KLH protein and enzyme-linked immunosorbent assay (ELISA) test kits for immune function testing, and Custom KLH formulations, adjuvants, conjugations and fill finishes for preclinical research and drug development applications.

MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-805-4882800
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive KLH News and Ratings via Email

Sign-up to receive the latest news and ratings for KLH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(KLH.V) (CVE:KLH) Frequently Asked Questions

What stocks does MarketBeat like better than (KLH.V)?

Wall Street analysts have given (KLH.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (KLH.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of (KLH.V) own?

What is (KLH.V)'s stock symbol?

(KLH.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KLH."

How do I buy shares of (KLH.V)?

Shares of KLH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is (KLH.V)'s official website?

The official website for (KLH.V) is stellarbiotechnologies.com.

How can I contact (KLH.V)?

(KLH.V)'s mailing address is 332 E Scott St, PORT HUENEME, CA 93041-2939, United States. The biotechnology company can be reached via phone at +1-805-4882800.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.